Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity

Ravi Kasiappan, Hung Ju Shih, Kang Lin Chu, Wei Ti Chen, Hui Ping Liu, Shiu Feng Huang, On Choy Chik, Chung Li Shu, Richard Din, Jan Show Chu, Hsin Ling Hsu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

MCT-1 oncoprotein accelerates p53 degradation by means of the ubiquitin-dependent proteolysis. Our present data show that induction of MCT-1 increases chromosomal translocations and deregulated G 2-M checkpoint in response to chemotherapeutic genotoxin. Remarkably, increases in chromosome copy number, multinucleation, and cytokinesis failure are also promoted while MCT-1 is induced in p53-deficient cells. In such a circumstance, the Ras-mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-mitogen-activated protein kinase signaling activity and the expression of metastatic molecules are amplified. Given a p53-silencing background, MCT-1 malignantly transforms normal breast epithelial cells that are satisfactory for stimulating cell migration/ adhesion and tumorigenesis. Detailed analyses of MCT-1 oncogenicity in H1299 p53-null lung cancer cells have shown that ectopically expressed MCT-1 advances xenograft tumorigenicity and angiogenesis, which cannot be completely suppressed by induction of p53. MCT-1 counteracts mutually with p53 at transcriptional levels. Clinical validations confirm that MCT-1 mRNA levels are differentially enriched in comparison between human lung cancer and nontumorigenic tissues. The levels of p53 mRNA are comparatively reduced in a subset of cancer specimens, which highly present MCT-1 mRNA. Our results indicate that synergistic promotions of chromosomal imbalances and oncogenic potency as a result of MCT-1 expression and p53 loss play important roles in tumor development.

Original languageEnglish
Pages (from-to)536-548
Number of pages13
JournalMolecular Cancer Research
Volume7
Issue number4
DOIs
Publication statusPublished - Apr 1 2009

Fingerprint

Chromosomal Instability
Messenger RNA
Lung Neoplasms
MAP Kinase Kinase Kinases
Tumor Suppressor Protein p53
Genetic Translocation
Cytokinesis
Extracellular Signal-Regulated MAP Kinases
Mutagens
Ubiquitin
Mitogen-Activated Protein Kinases
Heterografts
Cell Adhesion
Proteolysis
Cell Movement
Neoplasms
Carcinogenesis
Breast
Chromosomes
Epithelial Cells

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Kasiappan, R., Shih, H. J., Chu, K. L., Chen, W. T., Liu, H. P., Huang, S. F., ... Hsu, H. L. (2009). Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. Molecular Cancer Research, 7(4), 536-548. https://doi.org/10.1158/1541-7786.MCR-08-0422

Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. / Kasiappan, Ravi; Shih, Hung Ju; Chu, Kang Lin; Chen, Wei Ti; Liu, Hui Ping; Huang, Shiu Feng; Chik, On Choy; Shu, Chung Li; Din, Richard; Chu, Jan Show; Hsu, Hsin Ling.

In: Molecular Cancer Research, Vol. 7, No. 4, 01.04.2009, p. 536-548.

Research output: Contribution to journalArticle

Kasiappan, R, Shih, HJ, Chu, KL, Chen, WT, Liu, HP, Huang, SF, Chik, OC, Shu, CL, Din, R, Chu, JS & Hsu, HL 2009, 'Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity', Molecular Cancer Research, vol. 7, no. 4, pp. 536-548. https://doi.org/10.1158/1541-7786.MCR-08-0422
Kasiappan, Ravi ; Shih, Hung Ju ; Chu, Kang Lin ; Chen, Wei Ti ; Liu, Hui Ping ; Huang, Shiu Feng ; Chik, On Choy ; Shu, Chung Li ; Din, Richard ; Chu, Jan Show ; Hsu, Hsin Ling. / Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. In: Molecular Cancer Research. 2009 ; Vol. 7, No. 4. pp. 536-548.
@article{1d45699e5fae4c308b5cd0d422921ad4,
title = "Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity",
abstract = "MCT-1 oncoprotein accelerates p53 degradation by means of the ubiquitin-dependent proteolysis. Our present data show that induction of MCT-1 increases chromosomal translocations and deregulated G 2-M checkpoint in response to chemotherapeutic genotoxin. Remarkably, increases in chromosome copy number, multinucleation, and cytokinesis failure are also promoted while MCT-1 is induced in p53-deficient cells. In such a circumstance, the Ras-mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-mitogen-activated protein kinase signaling activity and the expression of metastatic molecules are amplified. Given a p53-silencing background, MCT-1 malignantly transforms normal breast epithelial cells that are satisfactory for stimulating cell migration/ adhesion and tumorigenesis. Detailed analyses of MCT-1 oncogenicity in H1299 p53-null lung cancer cells have shown that ectopically expressed MCT-1 advances xenograft tumorigenicity and angiogenesis, which cannot be completely suppressed by induction of p53. MCT-1 counteracts mutually with p53 at transcriptional levels. Clinical validations confirm that MCT-1 mRNA levels are differentially enriched in comparison between human lung cancer and nontumorigenic tissues. The levels of p53 mRNA are comparatively reduced in a subset of cancer specimens, which highly present MCT-1 mRNA. Our results indicate that synergistic promotions of chromosomal imbalances and oncogenic potency as a result of MCT-1 expression and p53 loss play important roles in tumor development.",
author = "Ravi Kasiappan and Shih, {Hung Ju} and Chu, {Kang Lin} and Chen, {Wei Ti} and Liu, {Hui Ping} and Huang, {Shiu Feng} and Chik, {On Choy} and Shu, {Chung Li} and Richard Din and Chu, {Jan Show} and Hsu, {Hsin Ling}",
year = "2009",
month = "4",
day = "1",
doi = "10.1158/1541-7786.MCR-08-0422",
language = "English",
volume = "7",
pages = "536--548",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity

AU - Kasiappan, Ravi

AU - Shih, Hung Ju

AU - Chu, Kang Lin

AU - Chen, Wei Ti

AU - Liu, Hui Ping

AU - Huang, Shiu Feng

AU - Chik, On Choy

AU - Shu, Chung Li

AU - Din, Richard

AU - Chu, Jan Show

AU - Hsu, Hsin Ling

PY - 2009/4/1

Y1 - 2009/4/1

N2 - MCT-1 oncoprotein accelerates p53 degradation by means of the ubiquitin-dependent proteolysis. Our present data show that induction of MCT-1 increases chromosomal translocations and deregulated G 2-M checkpoint in response to chemotherapeutic genotoxin. Remarkably, increases in chromosome copy number, multinucleation, and cytokinesis failure are also promoted while MCT-1 is induced in p53-deficient cells. In such a circumstance, the Ras-mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-mitogen-activated protein kinase signaling activity and the expression of metastatic molecules are amplified. Given a p53-silencing background, MCT-1 malignantly transforms normal breast epithelial cells that are satisfactory for stimulating cell migration/ adhesion and tumorigenesis. Detailed analyses of MCT-1 oncogenicity in H1299 p53-null lung cancer cells have shown that ectopically expressed MCT-1 advances xenograft tumorigenicity and angiogenesis, which cannot be completely suppressed by induction of p53. MCT-1 counteracts mutually with p53 at transcriptional levels. Clinical validations confirm that MCT-1 mRNA levels are differentially enriched in comparison between human lung cancer and nontumorigenic tissues. The levels of p53 mRNA are comparatively reduced in a subset of cancer specimens, which highly present MCT-1 mRNA. Our results indicate that synergistic promotions of chromosomal imbalances and oncogenic potency as a result of MCT-1 expression and p53 loss play important roles in tumor development.

AB - MCT-1 oncoprotein accelerates p53 degradation by means of the ubiquitin-dependent proteolysis. Our present data show that induction of MCT-1 increases chromosomal translocations and deregulated G 2-M checkpoint in response to chemotherapeutic genotoxin. Remarkably, increases in chromosome copy number, multinucleation, and cytokinesis failure are also promoted while MCT-1 is induced in p53-deficient cells. In such a circumstance, the Ras-mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-mitogen-activated protein kinase signaling activity and the expression of metastatic molecules are amplified. Given a p53-silencing background, MCT-1 malignantly transforms normal breast epithelial cells that are satisfactory for stimulating cell migration/ adhesion and tumorigenesis. Detailed analyses of MCT-1 oncogenicity in H1299 p53-null lung cancer cells have shown that ectopically expressed MCT-1 advances xenograft tumorigenicity and angiogenesis, which cannot be completely suppressed by induction of p53. MCT-1 counteracts mutually with p53 at transcriptional levels. Clinical validations confirm that MCT-1 mRNA levels are differentially enriched in comparison between human lung cancer and nontumorigenic tissues. The levels of p53 mRNA are comparatively reduced in a subset of cancer specimens, which highly present MCT-1 mRNA. Our results indicate that synergistic promotions of chromosomal imbalances and oncogenic potency as a result of MCT-1 expression and p53 loss play important roles in tumor development.

UR - http://www.scopus.com/inward/record.url?scp=65549131527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549131527&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-08-0422

DO - 10.1158/1541-7786.MCR-08-0422

M3 - Article

C2 - 19372582

AN - SCOPUS:65549131527

VL - 7

SP - 536

EP - 548

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 4

ER -